English: Well, I thank Jack Sargeant for that supplementary question, Llywydd, and for what he said about the efforts that he has seen himself on the ground by people going far beyond what their contract would expect, working in the evenings, working at weekends, doing everything they can to make sure that as many people as quickly as possible are vaccinated here in Wales. The problems that have been reported with the vaccine supply are just a warning to us that that supply chain does have fragilities in it. We were due four batches of the Oxford vaccine to Wales this week. One of those batches, very late in the process, was identified as needing some further attention and therefore couldn't come to us this week. Members will have read some of the concerns that have been expressed elsewhere in Europe about issues at the Belgian factory of the Pfizer company. I think Pfizer has since confirmed that there are some issues at that factory and that will have some impact on its ability to ramp up supplies in the way that it had anticipated. These are problems, however, that do not simply affect Wales. They affect all those places that are relying on the vaccine coming through in the way that we would all wish, and the impact of the Oxford vaccine issues wasn't just felt in Wales, it was felt in other parts of the United Kingdom as well. We remain confident - to go to Jack's point, we remain confident that we will deliver the promise we made, that those top four priority groups will be vaccinated by mid February, and the contribution of community pharmacy will not simply be in pharmacies themselves, but will be made by community pharmacists helping at mass vaccination centres, where the skills and the abilities that they have built up, through, for example, the flu vaccination programme, will be put to very good use in making sure that those vaccines are delivered as quickly as they possibly can be to people here in Wales.
Welsh: Wel, diolchaf i Jack Sargeant am y cwestiwn atodol yna, Llywydd, ac am yr hyn a ddywedodd am yr ymdrechion y mae wedi eu gweld ei hun ar lawr gwlad gan bobl sy'n mynd ymhell y tu hwnt i'r hyn y byddai eu contractau yn ei ddisgwyl, gan weithio fin nos, gweithio ar benwythnosau, gwneud popeth o fewn eu gallu i wneud yn siŵr bod cynifer o bobl yn cael eu brechu cyn gynted â phosibl yma yng Nghymru. Mae'r problemau a adroddwyd gyda'r cyflenwad brechlynnau yn rhybudd i ni bod mannau gwan yn y gadwyn gyflenwi honno. Roeddem ni i fod i gael pedwar cyflenwad o frechlyn Rhydychen i Gymru yr wythnos hon. Nodwyd, yn hwyr iawn yn y broses, bod angen rhoi sylw pellach i un o'r cyflenwadau hynny ac felly na allai ein cyrraedd ni yr wythnos hon. Bydd yr Aelodau wedi darllen rhai o'r pryderon a fynegwyd mewn mannau eraill yn Ewrop am broblemau yn ffatri cwmni Pfizer yng Nghwlad Belg. Rwy'n credu bod Pfizer wedi cadarnhau ers hynny bod rhai problemau yn y ffatri honno ac y bydd hynny yn cael rhywfaint o effaith ar ei gallu i gynyddu cyflenwadau yn y ffordd yr oedd wedi ei rhagweld. Mae'r rhain yn broblemau, fodd bynnag, nad ydyn nhw'n effeithio ar Gymru yn unig. Maen nhw'n effeithio ar yr holl leoedd hynny sy'n dibynnu ar i'r brechlyn gyrraedd yn y modd y byddem ni i gyd yn ei ddymuno, ac nid yng Nghymru yn unig y teimlwyd effaith problemau brechlyn Rhydychen, fe'i teimlwyd mewn rhannau eraill o'r Deyrnas Unedig hefyd. Rydym ni'n dal yn ffyddiog - i ymateb i bwynt Jack, rydym ni'n dal yn ffyddiog y byddwn ni'n cyflawni'r addewid a wnaed gennym, y bydd y pedwar prif grŵp blaenoriaeth hynny yn cael eu brechu erbyn canol mis Chwefror, ac ni fydd cyfraniad fferylliaeth gymunedol yn y fferyllfeydd eu hunain yn unig, ond yn cael ei wneud gan fferyllwyr cymunedol yn helpu mewn canolfannau brechu torfol, lle mae'r sgiliau a'r galluoedd y maen nhw wedi eu datblygu, drwy, er enghraifft, y rhaglen brechu rhag y ffliw, yn cael eu defnyddio yn dda iawn i wneud yn siŵr bod y brechlynnau hynny yn cael eu darparu cyn gynted â phosibl i bobl yma yng Nghymru.